Ridgewood, NJ, United States of America

Yoon T Jeon


Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 217(Granted Patents)


Company Filing History:


Years Active: 1997-2004

Loading Chart...
20 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Yoon T Jeon

Introduction: Yoon T Jeon is a prominent inventor based in Ridgewood, NJ, known for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 20 patents, his work focuses on developing novel compounds that have the potential to revolutionize treatments for various medical conditions.

Latest Patents: Yoon T Jeon's latest inventions showcase his expertise in medicinal chemistry. One notable patent involves imidazole and imidazoline derivatives, which serve as selective agonists for cloned human alpha adrenergic receptors. This invention offers promising applications for treating diseases that require modulation of these receptors, along with providing a pharmaceutical composition that includes a therapeutically effective amount of these compounds. Another significant patent details aryl sulfonamides and sulfamide derivatives designed to selectively bind to and inhibit the activity of the human Y5 receptor. This innovation presents potential therapeutic uses for addressing feeding disorders such as obesity, anorexia nervosa, and bulimia nervosa, as well as other conditions like hypertension and sleep disturbances.

Career Highlights: As an innovator at Synaptic Pharmaceutical Corporation, Yoon T Jeon has played a vital role in advancing research that bridges chemistry and pharmacology. His innovative spirit and commitment to improving patient outcomes have positioned him as a leading figure in his field.

Collaborations: Throughout his career, Yoon T Jeon has collaborated with esteemed colleagues like Charles Gluchowski and Wai C Wong. These partnerships have fostered an environment of shared knowledge and expertise, further enhancing the impact of their collective work in the pharmaceutical industry.

Conclusion: Yoon T Jeon's contributions to the field of pharmaceuticals underscore the importance of innovation in developing new therapies. His extensive patent portfolio reflects his dedication to improving medical treatments and highlights the potential for novel compounds to address complex health challenges. As he continues his work at Synaptic Pharmaceutical Corporation, the future looks promising for advancements in medicinal chemistry and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…